SELLAS Life Sciences to Present at the 2019 BIO CEO & Investor Conference
NEW YORK, Jan. 31, 2019 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a […]
NEW YORK, Jan. 31, 2019 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a […]
Oral and poster presentations on updated interim data from the Phase 2/3 trial of MarzAA for the treatment of hemophilia […]
EDEN PRAIRIE, Minn., Jan. 31, 2019 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), today announced the initiation of a distribution […]
FREMONT, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, […]
80% of Treated Patients with Clinical Response at 48 weeks, Published in Gastroenterology SAN DIEGO, Jan. 31, 2019 (GLOBE NEWSWIRE) […]
LONGUEUIL, Quebec, Jan. 31, 2019 (GLOBE NEWSWIRE) — Héroux-Devtek Inc. (TSX: HRX) OPEN TO: Analysts, investors and all interested parties […]
TORONTO, Jan. 31, 2019 (GLOBE NEWSWIRE) — dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) (“dynaCERT” or the “Company”) […]
THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES VAL-D’OR, Québec, Jan. 31, […]
Addition of the new GigaMesh wireless satellite to the fully configurable, EXOS-powered Smart Home and Business solution extends ubiquitous coverage […]
TORONTO, Jan. 31, 2019 (GLOBE NEWSWIRE) — Exco Technologies Limited (TSX-XTC) announced voting results from its 2019 annual meeting of […]